BIBLIO is the largest independent book marketplace in the world, with over 100 million books.

Skip to content

The End of Alzheimer's: The First Program to Prevent and Reverse Cognitive Decline

The End of Alzheimer's: The First Program to Prevent and Reverse Cognitive Decline

The End of Alzheimer's: The First Program to Prevent and Reverse Cognitive
Stock photo: cover may vary

The End of Alzheimer's: The First Program to Prevent and Reverse Cognitive Decline Hardback - 2017 - 1st Edition

by Dale Bredesen

Add to wish list
  • Used
  • very good
  • Hardback
Used - Very good

Description

Avery, August 2017. Hardcover. Very Good/Good. Some signs of wear but no defects. Light rubbing mark to front cover.
Ask the seller a question Add to wish list
A$6.38
A$5.32 Delivery within USA
Standard delivery: 2 to 8 days
More delivery options
Ships from Next Page Bookstore, LLC (Indiana, United States)

Details

  • Title The End of Alzheimer's: The First Program to Prevent and Reverse Cognitive Decline
  • Author Dale Bredesen
  • Binding Hardback
  • Edition number 1st
  • Edition 1
  • Condition Used - Very good
  • Pages 320
  • Volumes 1
  • Language ENG
  • Publisher Avery
  • Publication date August 2017
  • Illustrated Yes
  • Features Bibliography, Illustrated, Index
  • Bookseller's Inventory # 41643
  • ISBN 9780735216204 / 0735216207
  • Weight 1.05 lbs (0.48 kg)
  • Dimensions 9.1 x 6.2 x 1.3 in (23.11 x 15.75 x 3.30 cm)
  • Themes
    • Topical: Health & Fitness
  • Category Consumer Health
  • Library of Congress subjects Alzheimer's disease - Prevention, Alzheimer's disease - Treatment
  • Library of Congress Catalogue Number 2017029515
  • Dewey Decimal Code 616.831
  • Quantity available 1

About Next Page Bookstore, LLC Indiana, United States

Biblio member since 2019

The Next Page Bookstore & More is more than just a Bookstore! Established in August 2005, we offer a variety of new & gently used books, audio books, and gift items.

Terms of Sale:

30 day return guarantee, with full refund including original shipping costs for up to 30 days after delivery if an item arrives misdescribed or damaged.

We are unable to ship to any detention or correctional facilities. Any orders placed to these locations will be cancelled.

Browse books from Next Page Bookstore, LLC

Reader reviews for The End of Alzheimer's: The First Program to Prevent and Reverse Cognitive Decline

From the publisher

The instant New York Times and Wall Street Journal bestseller

A groundbreaking plan to prevent and reverse Alzheimer's Disease that fundamentally changes how we understand cognitive decline.

Everyone knows someone who has survived cancer, but until now no one knows anyone who has survived Alzheimer's Disease.

In this paradigm shifting book, Dale Bredesen, MD, offers real hope to anyone looking to prevent and even reverse Alzheimer's Disease and cognitive decline. Revealing that AD is not one condition, as it is currently treated, but three, The End of Alzheimer's outlines 36 metabolic factors (micronutrients, hormone levels, sleep) that can trigger "downsizing" in the brain. The protocol shows us how to rebalance these factors using lifestyle modifications like taking B12, eliminating gluten, or improving oral hygiene.

The results are impressive. Of the first ten patients on the protocol, nine displayed significant improvement with 3-6 months; since then the protocol has yielded similar results with hundreds more. Now, The End of Alzheimer's brings new hope to a broad audience of patients, caregivers, physicians, and treatment centers with a fascinating look inside the science and a complete step-by-step plan that fundamentally changes how we treat and even think about AD.

About the author

Dale Bredesen, M.D., is internationally recognized as an expert in the mechanisms of neurodegenerative diseases such as Alzheimer's disease. He graduated from Caltech, then earned his M.D. from Duke University Medical Center in Durham, North Carolina. He served as chief resident in neurology at the University of California, San Francisco (UCSF) before joining Nobel laureate Stanley Prusiner's laboratory at UCSF as an NIH postdoctoral fellow. He held faculty positions at UCSF, UCLA, and the University of California, San Diego. Dr. Bredesen directed the Program on Aging at the Burnham Institute before coming to the Buck Institute in 1998 as its founding president and CEO. He is the chief medical officer of MPI Cognition.
tracking-